Tivity Health (NASDAQ:TVTY) announced its quarterly earnings results on Wednesday. The company reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.01, Briefing.com reports. The firm had revenue of $214.10 million for the quarter, compared to the consensus estimate of $200.39 million. Tivity Health had a return on equity of 30.19% and a net margin of 16.30%. The business’s revenue was up 42.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.49 earnings per share. Tivity Health updated its FY 2019 guidance to $2.24-2.52 EPS and its FY19 guidance to $2.24-2.52 EPS.
Tivity Health stock opened at $20.31 on Friday. Tivity Health has a 12 month low of $16.25 and a 12 month high of $41.46. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.96 and a current ratio of 0.96. The company has a market capitalization of $1.09 billion, a PE ratio of 8.68, a PEG ratio of 0.89 and a beta of 1.10.
In related news, Director Sara Finley purchased 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 20th. The stock was acquired at an average cost of $17.25 per share, for a total transaction of $34,500.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Bradley S. Karro purchased 2,900 shares of the business’s stock in a transaction that occurred on Friday, March 22nd. The stock was bought at an average price of $16.54 per share, with a total value of $47,966.00. Following the completion of the purchase, the director now owns 24,696 shares of the company’s stock, valued at approximately $408,471.84. The disclosure for this purchase can be found here. 1.64% of the stock is currently owned by corporate insiders.
A number of equities analysts have weighed in on the company. BidaskClub raised Tivity Health from a “sell” rating to a “hold” rating in a research report on Tuesday, April 9th. Oppenheimer boosted their price target on Tivity Health from $31.00 to $36.00 in a research report on Thursday. Zacks Investment Research raised Tivity Health from a “hold” rating to a “strong-buy” rating and set a $25.00 target price on the stock in a research report on Wednesday, May 1st. Piper Jaffray Companies upped their target price on Tivity Health from $29.00 to $33.00 and gave the company an “overweight” rating in a research report on Thursday. Finally, Craig Hallum assumed coverage on Tivity Health in a research report on Thursday, April 11th. They issued a “buy” rating and a $30.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, eight have issued a buy rating and two have issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $33.00.
TRADEMARK VIOLATION NOTICE: This article was first published by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.baseballdailydigest.com/news/2019/05/10/tivity-health-tvty-announces-earnings-results.html.
About Tivity Health
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.
Further Reading: What is cost of equity?
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.